COMPASS THERAPEUTICS, INC. Public Float
COMPASS THERAPEUTICS, INC. (CMPX) had Public Float of $277.00 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $277.00M.
- 2024-06-30: Entity Public Float $98.00M.
- 2023-06-30: Entity Public Float $283.00M.
- 2022-06-30: Entity Public Float $184.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $277.00M 10-K · filed 2026-03-05 |
| 2024-06-30 | $98.00M 10-K · filed 2025-02-27 |
| 2023-06-30 | $283.00M 10-K · filed 2024-03-21 |
| 2022-06-30 | $184.00M 10-K · filed 2023-03-15 |
| 2021-06-30 | $180.00M 10-K · filed 2022-03-18 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-05 |
| 2019-09-30 | $0.00 10-K · filed 2020-06-08 |
| 2018-09-30 | $0.00 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |